Zivo Bioscience, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Zivo Bioscience, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q4 2023.
  • Zivo Bioscience, Inc. Common Stock, Shares, Issued for the quarter ending December 31, 2023 was 2.38M shares, a 51.7% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 2.38M +812K +51.7% Dec 31, 2023 10-K 2024-03-15
Q4 2022 1.57M -7.85M -83.3% Dec 31, 2022 10-K 2024-03-15
Q4 2021 9.42M -404M -97.7% Dec 31, 2021 10-K 2023-03-14
Q1 2021 421M +17.2M +4.27% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 413M 0 0% Dec 31, 2020 10-Q 2021-05-17
Q3 2020 407M +49.2M +13.7% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 407M +65M +19% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 404M +218M +117% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 413M +233M +129% Dec 31, 2019 10-K 2021-02-25
Q3 2019 358M +189M +112% Sep 30, 2019 10-Q 2019-10-28
Q2 2019 342M +181M +113% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 186M +44.9M +31.8% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 180M +38.9M +27.6% Dec 31, 2018 10-K 2020-03-26
Q3 2018 169M +27.6M +19.6% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 160M +21M +15.1% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 141M +3.84M +2.79% Mar 31, 2018 10-Q 2018-04-23
Q4 2017 141M +4.36M +3.19% Dec 31, 2017 10-K 2019-02-12
Q3 2017 141M +4.29M +3.14% Sep 30, 2017 10-Q 2017-10-19
Q2 2017 139M +6.53M +4.92% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 137M +4.77M +3.6% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 137M +4.59M +3.47% Dec 31, 2016 10-K 2018-02-21
Q3 2016 137M Sep 30, 2016 10-Q 2016-11-14
Q2 2016 133M +1.91M +1.46% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 133M +2.8M +2.16% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 132M +3.38M +2.63% Dec 31, 2015 10-K 2017-03-31
Q2 2015 131M +3.6M +2.83% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 130M +7.01M +5.7% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 129M +11.9M +10.2% Dec 31, 2014 10-K 2016-03-29
Q3 2014 129M +14.9M +13.2% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 127M +19.5M +18.1% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 123M +17.5M +16.6% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 117M +11.5M +11% Dec 31, 2013 10-K 2015-04-06
Q3 2013 114M +10.5M +10.1% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 108M +7.38M +7.34% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 105M +5.3M +5.3% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 105M +5.28M +5.28% Dec 31, 2012 10-K 2014-03-31
Q3 2012 103M +5.39M +5.51% Sep 30, 2012 10-Q/A 2012-11-19
Q2 2012 100M +3.79M +3.92% Jun 30, 2012 10-Q/A 2012-08-31
Q1 2012 100M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 100M +7.33M +7.91% Dec 31, 2011 10-K 2013-03-25
Q3 2011 97.8M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 96.6M Jun 30, 2011 10-Q/A 2011-09-13
Q4 2010 92.7M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.